Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:30 AM ET 8-K
Other 8-K Filing Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies Other 8-K Filing

Evolution Metals & Technologies Corp. issued a formal response refuting a short-seller report published by Capybara Research. The company categorically denied allegations of illegal payoffs and involvement with convicted felons, characterizing the report as a 'short and distort' market manipulation tactic.

Counterparty
Capybara Research
8:00 AM ET 8-K
Other 8-K Filing Natural Grocers by Vitamin Cottage, Inc. NGVC

Natural Grocers by Vitamin Cottage Other 8-K Filing

Natural Grocers by Vitamin Cottage completed its reincorporation from Delaware to Texas effective November 16, 2026. Each share of Delaware common stock was automatically converted into one share of Texas common stock, with no changes to the company's business, management, or NYSE listing (NGVC).

6:34 PM ET 8-K
Other 8-K Filing Aspira Women's Health Inc. AWHL

Aspira Women's Health Other 8-K Filing

Aspira Women's Health announced that its previously issued financial statements for the first two quarters of 2026 should no longer be relied upon due to material errors in the Statement of Cash Flows. The errors involved the misclassification of loan proceeds and repayments as operating activities instead of financing activities. The company plans to restate these periods, though the adjustments have no impact on the reported balance sheets, statements of operations, or total net change in cash.

6:33 PM ET 8-K
Other 8-K Filing Boumarang Inc.

Boumarang Other 8-K Filing

Boumarang Inc. announced that its financial statements for the quarter ended June 30, 2026, should no longer be relied upon due to an accounting error regarding its investment in Nuvora Energy, Inc. The company failed to record a $1.0 million unrealized gain following an observable price change in Nuvora's equity, resulting in a restatement that turns a previously reported Q2 net loss into net income. Management identified a material weakness in internal control over financial reporting as a result of the error.

Counterparty
Nuvora Energy, Inc.
6:33 PM ET 8-K
Other 8-K Filing Modexus Solutions, Inc. MOD

Modexus Solutions Other 8-K Filing

Modine Manufacturing Company has officially changed its corporate name to Modexus Solutions, Inc. following shareholder approval at a special meeting. The rebranding reflects the company's strategic shift toward high-growth thermal management solutions for data centers and commercial HVAC markets following the spin-off of its Performance Technologies business.

4:46 PM ET 8-K
Other 8-K Filing Century Casinos Inc CNTY

Century Casinos Other 8-K Filing

Century Casinos announced that its financial statements for fiscal years 2024 and 2025, and the first two quarters of 2026, should no longer be relied upon due to accounting errors. The misstatement relates to the accounting for a 50% interest in Smooth Bourbon, LLC, which owns the real estate for the Nugget Casino Resort. The company expects to report at least one material weakness in its internal control over financial reporting as a result of the restatement.

4:38 PM ET 8-K
Other 8-K Filing Bnb Plus Corp. BNBX

Bnb Plus Other 8-K Filing

BNB Plus Corp. entered into a Conversion and Inducement Agreement where holders of Series B-1 Preferred Stock converted 1,282,852 shares into common stock on a one-for-one basis. As an inducement for the conversion, the company paid the holders an aggregate cash payment of approximately $2.02 million ($1.575 per share). This transaction represents a preferred equity redemption settled in common stock with a cash inducement, rather than a new capital raise or debt issuance.

Counterparty
Holders of Series B-1 Preferred Stock
4:28 PM ET 8-K
Other 8-K Filing Dave Inc. DAVE

Dave Other 8-K Filing

Dave Inc. has filed applications with the OCC and FDIC to establish Dave Bank, N.A. as a full-service national bank and wholly-owned subsidiary. The company also intends to apply to the Federal Reserve to become a bank holding company, a move intended to allow Dave to offer deposit and credit products directly under federal supervision. In connection with the application, Anthony Sharett has been appointed as Chief Banking Officer and proposed President of the Bank.

Counterparty
Office of the Comptroller of the Currency (OCC)
3:26 PM ET 8-K
Other 8-K Filing Pyrophyte Acquisition Corp. PHYT

Pyrophyte Acquisition Other 8-K Filing

Pyrophyte Acquisition Corp. announced that its sponsor, Pyrophyte Acquisition LLC, deposited $300,000 into the company's trust account. This payment covers the fifth, sixth, and seventh monthly extension installments required to extend the deadline for the company to complete its initial business combination to April 29, 2027.

Counterparty
Pyrophyte Acquisition LLC
Term
3 months
2:33 PM ET 8-K
Other 8-K Filing Vistra Corp. VST

Vistra Other 8-K Filing

Vistra Corp. announced an annual tax payment of approximately $91,056 to holders of rights under its Amended and Restated Tax Receivable Agreement. The payment, scheduled for November 30, 2026, relates to the 2025 taxable year and consists of $72,149 as return of basis and $18,907 as interest income. This follows approximately $57.9 million in prior payments made in respect of these TRA Rights.

Counterparty
Equiniti Trust Company, LLC
2:16 PM ET 8-K
Other 8-K Filing Regenerex Pharma, Inc. RGPX

Regenerex Pharma Other 8-K Filing

Regenerex Pharma, Inc. has appointed Rosenfield and Company PLLC CPA as its new independent registered public accounting firm. The new auditor is currently preparing the company's past-due Form 10-Q filings to bring the company current with its SEC reporting obligations.

Counterparty
Rosenfield and Company PLLC CPA
9:19 AM ET 8-K
Other 8-K Filing Lincoln National Life Insurance Co

Lincoln National Life Insurance Other 8-K Filing

The Lincoln National Life Insurance Company determined that its financial statements for fiscal years 2024 and 2025, and the first two quarters of 2026, should no longer be relied upon due to a mechanical error in 'shadow adjustments' related to reinsurance. The restatement is expected to decrease Accumulated Other Comprehensive Income (AOCI) by approximately $1.2 billion as of December 31, 2025, and $1.9 billion as of December 31, 2024.

Counterparty
Ernst & Young LLP
8:06 AM ET 8-K
Other 8-K Filing Our Bond, Inc. OBAI

Our Bond Other 8-K Filing

Our Bond, Inc. entered into agreements to convert Series B Preferred Stock with a total stated value of $13.26 million into 6,532,640 shares of common stock at a conversion price of $2.03 per share. The transaction reduces the company's total outstanding preferred liquidation preference from approximately $20.9 million to $7.6 million. Participating holders, including the CEO and an independent director, are subject to a six-month lock-up period followed by volume-based resale restrictions.

6:31 AM ET 8-K
Other 8-K Filing Sono Group N.V. SSM

Sono Group Other 8-K Filing

Sono Group N.V. filed a supplement to its proxy statement regarding its proposed redomiciliation from the Netherlands to Delaware. The update reflects the conversion of 12.5 preferred shares into 375,000 ordinary shares, adjusting the total voting power and share count as of the November 13, 2026 record date.

6:15 AM ET 8-K
Other 8-K Filing Oz Vision Inc. OZVN

Oz Vision Other 8-K Filing

OZ Vision Inc. announced that its audited financial statements for the fiscal years ended June 30, 2025, and June 30, 2026, should no longer be relied upon due to material misstatements regarding intangible assets. The company discovered that a $12.57 million Nevada State Athletic Commission license it had recorded was never validly transferred to the company and was non-transferable. The restatement is expected to eliminate approximately $13.1 million in assets, resulting in a total stockholders' deficit as of June 30, 2026.

Counterparty
Boladale Lawal & CO
6:14 AM ET 8-K
Other 8-K Filing Summit Therapeutics Inc. SMMT

Summit Therapeutics Other 8-K Filing

Summit Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for ivonescimab in combination with chemotherapy for certain lung cancer patients. The FDA determined that the BLA cannot be approved in its current form because the progression-free survival benefit did not establish substantial evidence of effectiveness without a statistically significant improvement in overall survival.

Counterparty
FDA
5:25 PM ET 8-K
Other 8-K Filing Mangoceuticals, Inc. MGRX

Mangoceuticals Other 8-K Filing

Mangoceuticals amended its Series B and Series C preferred stock designations and established a new Series D Preferred Stock class. The Series D Preferred Stock will rank senior to common stock and existing preferred classes regarding dividends and liquidation, though no shares were issued at the time of filing. The amendments include waivers from existing preferred holders to allow for the senior ranking and future Series D transactions.

5:20 PM ET 8-K
Other 8-K Filing Panamera Holdings Corp PHCI

Panamera Holdings Other 8-K Filing

Panamera Holdings Corp announced that its previously issued financial statements for the fiscal year ended July 31, 2025, can no longer be relied upon. The non-reliance is due to an unreported employment agreement and a resulting lawsuit that impacted the company's financial reporting. The company is currently in the process of restating these financial statements and plans to file an amended Annual Report on Form 10-K as soon as practicable.

5:18 PM ET 8-K12B
Other 8-K Filing Versa Bancorp VRSA

Versa Bancorp Other 8-K Filing

VersaBank completed a corporate reorganization to establish Versa Bancorp, a Delaware corporation, as its new U.S. bank holding company. Each outstanding common share of VersaBank was exchanged for one share of Versa Bancorp common stock, which will trade on Nasdaq and the TSX under the new ticker 'VRSA' starting around November 17, 2026.

5:00 PM ET 8-K
Other 8-K Filing byNordic Acquisition Corp BYNO

byNordic Acquisition Other 8-K Filing

byNordic Acquisition Corp deposited $8,850.20 into its trust account to extend the deadline for completing its initial business combination by one month. The extension moves the termination date from November 12, 2026, to December 12, 2026, and represents the fourth of twelve possible monthly extensions.

Term
1 month
4:53 PM ET 8-K
Other 8-K Filing Santander Holdings USA, Inc. SNUS-PH

Santander Holdings USA Other 8-K Filing

Santander Holdings USA, Inc. is recasting its historical financial statements for 2023, 2024, and 2025 to reflect changes in its internal management reporting structure. The company combined its Commercial & Industrial and Commercial Real Estate segments into a single Commercial Banking segment, and this filing provides the recast segment data for informational purposes without restating overall consolidated results.

4:46 PM ET 8-K
Other 8-K Filing Apnimed, Inc. APMD

Apnimed Other 8-K Filing

Apnimed, Inc. announced that its previously issued financial statements for the three and six months ended June 30, 2026, should no longer be relied upon due to an accounting error. The error involves the misclassification of an $85.4 million gain from the sale of its interest in Shionogi-Apnimed Sleep Science, LLC as continuing operations rather than discontinued operations. The company intends to file a restatement on Form 10-Q/A to correct the classification, which does not impact total net income, cash, or total assets.

Counterparty
Shionogi & Co., Ltd.
4:37 PM ET 8-K
Other 8-K Filing Dhi Group, Inc. DHX

Dhi Group Other 8-K Filing

DHI Group, Inc. entered into a First Amendment to its Section 382 Rights Agreement with Computershare Trust Company, N.A. to clarify definitions of beneficial ownership. The amendment provides specific conditions under which requests for exemption from the rights agreement will be granted based on Section 382 of the Internal Revenue Code.

Counterparty
Computershare Trust Company, N.A.
4:35 PM ET 8-K
Other 8-K Filing Keycorp KEY

Keycorp Other 8-K Filing

KeyCorp has issued a notice to redeem all 20,000,000 outstanding depositary shares of its Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock on December 15, 2026. The redemption will be for cash at a price of $25.3828125 per depositary share, representing the $500 million aggregate liquidation preference plus accumulated dividends. Following the redemption, the Series E preferred stock will be delisted from the New York Stock Exchange.

4:25 PM ET 8-K
Other 8-K Filing Goldman Sachs Group Inc GS

Goldman Sachs Group Other 8-K Filing

Goldman Sachs filed Certificates of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series O and Series V Preferred Stock. This administrative action follows the full redemption of all outstanding shares of both series on November 10, 2026.

4:18 PM ET 8-K
Other 8-K Filing Pyxis Oncology, Inc. PYXS

Pyxis Oncology Other 8-K Filing

Pyxis Oncology stockholders approved an amendment to the company's Certificate of Incorporation to double the number of authorized shares of common stock from 190 million to 380 million. The amendment became effective upon filing with the Secretary of State of Delaware on November 13, 2026. No shares were issued or sold as part of this filing, which primarily serves to reserve capacity for future corporate purposes.

4:17 PM ET 8-K
Other 8-K Filing Conx Corp. CNXX

Conx Other 8-K Filing

CONX Corp. announced that its financial statements for the fiscal year ended December 31, 2024, should no longer be relied upon due to an error in the consolidated statement of cash flows. The error involved the incorrect classification of interest income on cash equivalents, and correcting it will shift approximately $5.9 million from investing activities to operating activities. The restatement has no impact on the company's net income, total assets, or cash position.

4:06 PM ET 8-K
Other 8-K Filing Athena Technology Acquisition Corp. II ATEK

Athena Technology Acquisition Corp. II Other 8-K Filing

Athena Technology Acquisition Corp. II deposited $271.48 into its trust account to extend the deadline for completing its initial business combination by one month. This Monthly Extension moves the deadline from November 14, 2026, to December 14, 2026, and represents the sixth of nine permitted monthly extensions.

Term
1 month
4:03 PM ET 8-K
Other 8-K Filing CNO Financial Group, Inc. CNO

CNO Financial Group Other 8-K Filing

CNO Financial Group entered into a Sixth Amended and Restated Section 382 Rights Agreement to extend its existing 'poison pill' through November 13, 2029. The agreement is designed to protect the company's tax net operating loss carryforwards by deterring any person from acquiring 4.99% or more of the company's outstanding common stock without board approval.

Counterparty
Equiniti Trust Company, LLC
Term
3 years
1:09 PM ET 8-K
Other 8-K Filing IIOT-OXYS, Inc. ITOX

IIOT-OXYS Other 8-K Filing

IIOT-OXYS, Inc. entered into exchange agreements to settle outstanding debt and existing preferred stock obligations. The company issued 70.22 shares of Series E Preferred Stock to Scott Cox to satisfy $84,262 in reimbursement obligations for professional services, and issued 63.67 shares of Series E Preferred Stock to three holders in exchange for all 57 outstanding shares of Series C Preferred Stock.

Counterparty
Scott Cox

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.